Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 25, 2021
Patent Application Number
16827302
Date Filed
March 23, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure provides compositions and methods for making and using engineered killer phagocytic cells for immunotherapy in cancer or infection by expressing a chimeric antigen receptor having an enhanced phagocytic activity, the chimeric receptor is encoded by a recombinant nucleic acid.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
